Zimmer Biomet (NYSE:ZBH) today said it has appointed Ivan Tornos to the newly-created role of chief operating officer.
Tornos previously served as group president of orthopedics and was later appointed group president of global businesses and the Americas.
As chief operating officer, Tornos will be responsible for overseeing all global businesses at Zimmer Biomet, as well as leading global operations, clinical and medical education and global R&D and new product development functions. He will also be responsible for oversight of the Europe, Middle East and Africa region with the president of EMEA reporting to him. Tornos will report to president and CEO Bryan Hanson.
“Since joining Zimmer Biomet, Ivan has made tremendous contributions toward the strategic evolution of our business, delivering consistent results across the board,” Hanson said in a news release. “As we continue to transform the company, having Ivan at the helm in this newly-created and expanded role to drive forward, align and execute on our operations helps ensure we continue to deliver for our customers, patients and shareholders.”
Prior to joining Zimmer Biomet, Tornos served and president of global urology, medical and critical care at BD. He also held numerous leadership roles at C.R. Bard, Covidien, Baxter and Johnson & Johnson.